• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Consumers

  • Print
  • Share
  • E-mail

Notification of Counterfeit Serostim


Serono, Inc. became aware of a counterfeit lot of Serostim [somatropin (rDNA
origin) for injection]. The counterfeit material has been packaged to appear
as drug product lot number S810-1A1. This is not a legitimate Serostim lot
number. Preliminary information appears to indicate that the counterfeit
material may have been distributed via the Internet. However, pharmacists
should examine Serostim prior to dispensing to ensure that the package does
not bear lot number S810-1A1.

Patients should also check the product in their possession to ensure it does not
bear the lot number S810-1A1.

You may access the MedWatch 2002 safety information summary, including links to the
current press release, Dear Doctor Letter, and past MedWatch alerts regarding Serostim, at:


Richard Klein
Office of Special Health Issues
Food and Drug Administration